Today: 2. May, 2025
After a brief hiatus due to health concerns, King Charles III is poised to return to public engagements next week, signaling a significant recovery from his recent cancer treatment. Buckingham Palace confirmed that the 75-year-old monarch, along with Queen Camilla, will initiate…
In a significant strategic move, pharmaceutical giant Johnson & Johnson has announced a definitive agreement to acquire Ambrx Biopharma, a pioneering cancer drug developer, for an impressive $2 billion in cash. This acquisition, revealed on the first day of the annual JPMorgan…
